Addex Expands Pipeline With Selective M4 PAM Program For Schizophrenia & Other Psychotic Disorders
- ByBenzinga-
Addex Therapeutics (NASDAQ: ADXN) has moved a selective and potent M4 muscarinic receptor positive allosteric modulator (PAM) program into lead optimization, with a potential...